A randomized trial comparing tamoxifen therapy vs. Tamoxifen prophylaxis in bicalutamide-induced gynecomastia

Clinical Genitourinary Cancer

Volumn 10, Issue 3, 2012, Pages 174-179

  Serretta, Vincenzo ^a   Altieri, Vincenzo ^b   Morgia, Giuseppe ^c   Nicolosi, Federico ^d   De Grande, Gaetano ^d   Mazza, Rosaria ^e   Melloni, Darwin ^a   Allegro, Rosalinda ^f   Ferraù, Francesco ^g   Gebbia, Vittorio ^h  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Garibaldi Central Hospital   (Italy)

^e Civic Hospital Garibaldi   (Italy)

^f GSTU Foundation   (Italy)

^g San Vincenzo Hospital   (Italy)

^h UNIVERSITY OF PALERMO   (Italy)

Author keywords

Antiandrogen; Bicalutamide; Breast pain; Gynecomastia; Prostate cancer

Indexed keywords

BICALUTAMIDE; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; ECHOGRAPHY; GYNECOMASTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MONOTHERAPY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ANILIDES; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; ESTROGEN ANTAGONISTS; GYNECOMASTIA; HUMANS; MALE; MIDDLE AGED; NITRILES; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; TAMOXIFEN; TOSYL COMPOUNDS; TREATMENT OUTCOME;

EID: 84864972547     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2012.03.002     Document Type: Article

References (17)

1. F. Boccardo Hormone therapy of prostate cancer: is there a role for antiandrogen monotherapy? Crit Rev Oncol/Hematol 35 2000 121 132 (Pubitemid 30599435)
2. P. Iversen, C.J. Tyrrell, A.V. Kaisary Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup J Urol 164 2000 1579 1582
3. D.G. McLeod, P. Iversen, W.A. See Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer BJU Int 97 2006 247 254
4. P. Iversen Quality of life issues relating to endocrine treatment options Eur Urol 36 suppl 2 1999 20 26 (Pubitemid 29478971)
5. G. Di Lorenzo, S. Perdonà, S. De Placido Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy J Urol 174 2005 2197 2203 (Pubitemid 41611773)
6. A.C. Eaton, A. Makris, A. Makris Once weekly tamoxifen in the prevention of gynaecomastia and breast pain secondary to bicalutamide therapy J Urol 171 suppl 4 2004 282 Abstract Number 1069
7. F. Boccardo, A. Rubagotti, M. Battaglia Evaluation of tamoxifen and anastrozole in the prevention of gynaecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer J Clin Oncol 23 2005 808 815
8. D. Saltzstein, P. Sieber, T. Morris Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole Prostate Cancer Prostatic Dis 8 2005 75 83
9. S. Perdonà, R. Autorino, S. De Placido Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial Lancet Oncol 6 2005 295 300 (Pubitemid 40590266)
10. W. See, P. Iversen, L. Wirth Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer Eur Urol 44 2003 512 518 (Pubitemid 37328624)
11. H. Van Poppel, C.J. Tyrrell, K. Haustermans Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer Eur Urol 47 2005 587 592 (Pubitemid 40521901)
12. A. Dobs, M.J. Darkes Incidence and management of gynecomastia in men treated for prostate cancer J Urol 174 2005 1737 1742 (Pubitemid 41546924)
13. H. Van Poppel, B. Tombal, P.J. Van Cangh Development and validation of a new questionnaire to assess gynaecomastia and breast pain in patients receiving bicalutamide Eur Urol 4 suppl 2005 80
14. Y. Fradet, B. Egerdie, M. Andersen Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150mh monotherapy in patients with prostate cancer: a randomized, placebo-controlled, dose-response studyTamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study Eur Urol 52 2007 106 115 (Pubitemid 46823894)
15. D. Bedognetti, A. Rubagotti, G. Conti An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients Eur Urol 57 2010 238 245
16. T.F. Anelli, A. Anelli, K.N. Tran Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients Cancer 74 1994 74 77 (Pubitemid 24187612)
17. G. Di Lorenzo, R. Autorino Bicalutamide-induced gynaecomastia: do we have the answer? Eur Urol 52 2007 5 8 (Pubitemid 46803018)